Analyst Reco. Instil Bio, Inc.

Equities

TIL

US45783C2008

Market Closed - Nasdaq Other stock markets 02:00:00 03/05/2024 am IST			5-day change	1st Jan Change
11.22 ^USD	+4.66%		+7.88%	+47.24%

26/04	Instil Bio, Inc. Announces Board Changes	CI
15/04	North American Morning Briefing : Stock Futures -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Downgrades Instil Bio to Hold From Buy	12/04	MT
HC Wainwright Initiates Instil Bio With Buy Rating, $2 Price Target	29/23/29	MT
Truist Securities Reinstates Instil Bio at Hold	05/23/05	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $2 From $6, Keeps Equalweight Rating	12/22/12	MT
Baird Lowers Price Target on Instil Bio to $14 From $24, Maintains Outperform Rating	17/22/17	MT
Morgan Stanley Adjusts Instil Bio Price Target to $6 From $8, Maintains Equal Weight Rating	01/22/01	MT
Baird Adjusts Instil Bio's Price Target to $24 From $31, Keeps Outperform Rating	01/22/01	MT
Cowen Downgrades Instil Bio to Market Perform From Outperform	01/22/01	MT
Baird Lowers Price Target on Instil Bio to $31 From $34, Maintains Outperform Rating	06/22/06	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $8 From $9, Maintains Equalweight Rating	24/22/24	MT
Truist Securities Adjusts Instil Bio's Price Target to $16 from $25, Maintains Buy Rating	23/22/23	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $9 From $14, Keeps Equalweight Rating	06/22/06	MT
Instil Bio Shares Drop 35% After FDA IND Clearance and Truist Price Target Cut	27/22/27	DJ
Morgan Stanley Adjusts Instil Bio Price Target to $14 From $15, Maintains Equal Weight Rating	24/22/24	MT
INSTIL BIO : Baird Starts Instil Bio at Outperform With $34 Price Target	13/21/13	MT
INSTIL BIO : Morgan Stanley Adjusts Instil Bio's Price Target to $23 From $24, Keeps Equal-Weight Rating	26/21/26	MT
INSTIL BIO : Jefferies Starts Instil Bio at Buy with $31 Price Target	13/21/13	MT
INSTIL BIO : Cowen Starts Instil Bio at Outperform	13/21/13	MT
INSTIL BIO : Morgan Stanley Initiates Coverage on Instil Bio With Equal-Weight Rating, $24 Price Target	13/21/13	MT
INSTIL BIO : Truist Securities Starts Instil Bio at Buy With $32 Price Target	13/21/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Instil Bio, Inc.

Equities

TIL

US45783C2008

Analyst Reco.

Filters